The Danish capital’s entrepreneurial ecosystem is unique according to Daiichi Sankyo´s Global Chief of Research and Development, Antoine Yver
COBIS-based MVA-member, Japanese oncology company, Daiichi Sankyo, established their Nordic headquarter in Copenhagen last year. This was absolutely no coincidence according to Daiichi Sankyo´s Global Chief of Research and Development, Antoine Yver (standing left), who motivates their decision in a recently published interview with the Danish Ministry of Foreign Affairs. The specific choice of COBIS is furthermore motivated and elaborated by Managing Director and Head of Commercial Operations in the European Oncology department, Patrik Grandits (second from right). Read full interview here.